What’s new in #HF June-July 24? smartphone-approach to #HF dx. #MRA efficacy + safety in pts with ⬇️ renal function. Timing to LVEF recovery 🤔? When #ICD. #SGLT2i in ATTR-CM ⬇️CV➕ HF🏥 👉 bit.ly/3xRJ7Sa EJHF Editor-in-Chief Amr Abdin Alberto Aimo Daniela Tomasoni

Otro enorme avance en el manejo de los pacientes con amiloidosis cardiaca por transtiretina #ESCCongress #vutrisiran NEJM European Society of Cardiology Vurtrisiran silenciador 🧬 administrado 💉 sc cada 3 meses vs placebo ✅ ⤵️ 28% en el riesgo de muerte por todas las causas o eventos 🏥 por IC

#Aficamten 4/6 presentation This is a study from #FOREST-HCM trial where we withdrew beta blockers/calcium channel blockers/disopyramide from patients with obstructive #HCM on stable dose of aficamten. What did we find? #ESCCongress #CardioTwitter

🗞️ The #RevascHeart study : Revascularization and outcomes in ischaemic left ventricular dysfunction after #HeartFailure admission European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han HFAPresident bit.ly/4evdb6b

What’s new in #HF Oct 2024? doi.org/10.1002/ejhf.3… #Finerenone #FINEARTS-HF #FINE-HEART #Semaglutide #STEP-#HFpEF #SELECT #FLOW #MitraClip #RESHAPE-HF2 #MATTERHORN #Vutrisiran #HELIOS-B #Aficamten #SEQUOIA-#HCM #FOREST-HCM Pau Codina Verdaguer Daniela Tomasoni Alberto Aimo European Society of Cardiology Journals

What's new in heart failure? October 2024 Highlights from the European Society of Cardiology meeting showcase several groundbreaking advancements in #HF research European Society of Cardiology Journals Alberto Aimo 👇🏻📝 onlinelibrary.wiley.com/doi/10.1002/ej… #EJHF Henry Han Giuseppe Galati Amr Abdin

What’s new in #HF Dec 2024? doi.org/10.1002/ejhf.3… #GDMT in ESC HF III Registry #HFimpEF predictors LV vol & exe capacity in #HFpEF HFpEF in repaired #Coarctation Aorta #CMR #DCMmrEF risk stratificatn #Chagas cardiomyopathy Pau Codina Verdaguer @DaniTomasoni Alberto Aimo European Society of Cardiology Journals

What's new in #HeartFailure ? December 2024 onlinelibrary.wiley.com/doi/full/10.10… #EJHF EJHF Editor-in-Chief

Remote PA pressure monitoring: a promising tool for better heart failure care. Check out the new HFA consensus! onlinelibrary.wiley.com/doi/10.1002/ej… #HeartFailure #ESC

This clinical consensus statement summarizes current knowledge on remote #PAP-guided management of patients with HF, with a special focus on current evidence from clinical trials, potential impact on clinical practice and management aspects. #HFA European Society of Cardiology Journals #EJHF

A really important editorial in JAMA regarding the next big area of low-value, potentially harmful intervention -- on tricuspid regurgitation. Every paragraph is spot on.

🔴What's new in heart failure? April 2025⤵️ European Society of Cardiology Journals 🔹onlinelibrary.wiley.com/doi/abs/10.100… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd

Aquest dimecres 18 de juny s'organitza la 𝟏𝐚 𝐉𝐨𝐫𝐧𝐚𝐝𝐚 𝐝𝐞 𝐂𝐚𝐫𝐝𝐢𝐨𝐩𝐚𝐭𝐢𝐞𝐬 𝐅𝐚𝐦𝐢𝐥𝐢𝐚𝐫𝐬 promoguda per la Unitat d’Insuficiència Cardíaca de l'L'Institut del Cor del Germans Trias. 🗓️ 18 de juny ⏰ 15:45h 📍Sala d'actes Hosp. Germans Trias #iCorGermansTrias #HGermansTrias #Cardiologia

El Dr. Pau Codina, Metge Adjunt de la Unitat d'Insuficiència Cardíaca, ha defensat aquesta setmana la seva tesi doctoral, titulada 'Valoració del Risc en Insuficiència Cardíaca', dirigida pel Dr. Antoni Bayés i la Dra. Elisabet Zamora. Enhorabona, Pau! 👏🏻 #iCorGermansTrias

What’s new in #HF June 2025? 🔗 doi.org/10.1002/ejhf.3… 💧 Natriuresis & congestion 📡 Remote PAP monitoring 💔 Acute & advanced HF 🧬 Cardio-oncology 🔍 HFmrEF/HFpEF 🩸 IV iron Pau Codina Verdaguer @DaniTomasoni Alberto Aimo European Society of Cardiology Journals

🚨💊 ¿Un fármaco del siglo XVIII puede mejorar el pronóstico en insuficiencia cardíaca en plena era de ARNI y SGLT2i? 👉 El ensayo DIGIT-HF con digitoxina acaba de publicarse en NEJM. Te cuento los resultados que sorprendieron positivamente en el #ESCcongress 2025🧵👇

#VICTOR #ESCCongress #LBCT 🫀Vericiguat in Chronic #HFrEF 🫀population:1/2 no prior HF hospitalization, excellent GDMT 🫀 Nonetheless, no significant finding of difference of Vericiguat 🆚 Placebo 🫀did ⤵️ risk of CV death

MAPLE HCM presented by Pablo Garcia-Pavia #ESC2025 #cardiotwitter